Co-authored with Mark Kalinich, MD, PhD, at the Division of Digital Psychiatry at BIDMC. A patient tells you she has been using a general-purpose AI chatbot late at night when she feels anxious. As a ...

NERC sees no high-risk grid regions this summer—but analysts warn it's a reprieve, not a fix, as data center load returns by ...

GLP 1 study conversations just took a turn from health talk to workplace reality, and the findings are uncomfortable. According to new research from Harvard University economist Rebecca Diamond found ...

AlzeCure licensed NeuroRestore ACD856 to QuantumCell in a deal worth over $2.2B. The real story is not proof, but Alzheimer’s ...

Ocugen has no product revenue, remains loss-making, and the convertible notes add debt burden and potential share dilution. Learn more about OCGN stock here.

We've got the answers to all quiz questions in College Football 27's Road to Glory, so find out how to get a perfect score ...

The great housing melt continues. A crash in Canada was never in the cards. Never likely. Never happened. Never will. Real ...

XRP trades near $1.08 as of July 8, 2026, giving back about 4% on the day as the broader market cools — Bitcoin eased to roughly $62,000 after Strategy’s record treasury sale — and the token retests ...

Objective Phase II trials suggest glucagon-like peptide-1 receptor (GLP1) agonists resolve metabolic dysfunction-associated steatohepatitis but do not affect fibrosis regression. We aimed to determine ...

Regarding your proposal (hard isolation, compression loops, confidence gating, external KV cache) — I cannot evaluate its technical soundness. But I will record your report and its status in my ...